Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2007
03/15/2007US20070059286 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity
03/15/2007US20070059280 Inhibitors of colony stimulating factors
03/15/2007US20070059275 Antibody toxin conjugates
03/15/2007US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent
03/15/2007CA2812794A1 Targeted identification of immunogenic peptides
03/15/2007CA2812110A1 Targeted identification of immunogenic peptides
03/15/2007CA2808659A1 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
03/15/2007CA2808179A1 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
03/15/2007CA2662798A1 Antibodies as t cell receptor mimics, methods of production and uses thereof
03/15/2007CA2629393A1 Solid solution perforator containing drug particle and/or drug-adsorbed particles
03/15/2007CA2621992A1 Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists
03/15/2007CA2621666A1 Antigens for vaccination against and detection of mycoplasma suis
03/15/2007CA2621502A1 Toxin conjugated eph receptor antibodies
03/15/2007CA2621439A1 Methods and compositions for diagnosis and immunotherapy of pollen allergy
03/15/2007CA2621414A1 Mmp-7 and adf derived tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules
03/15/2007CA2621389A1 Tumor-associated peptides binding promiscuously to human leukocyte antigen (hla) class ii molecules
03/15/2007CA2621279A1 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
03/15/2007CA2621025A1 An ultra-high yield intravenous immune globulin preparation
03/15/2007CA2620727A1 Porcine circovirus type 2 vaccine
03/15/2007CA2620713A1 Immunoglobulin comprising predominantly a man7glcnac2, man8glcnac2 glycoform
03/14/2007EP1762620A2 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
03/14/2007EP1762619A2 Multiple-tumor aberrant growth genes
03/14/2007EP1762617A1 Method for manufacturing recombinant polyclonal proteins
03/14/2007EP1762246A1 Multivalent DTP-Polio vaccines
03/14/2007EP1762245A2 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
03/14/2007EP1761635A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof
03/14/2007EP1761566A1 Humanized anti-tag-72 monoclonal antibodies
03/14/2007EP1761563A2 HUMANIZED Fc gamma RIIB SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
03/14/2007EP1761562A2 Conformation specific antibodies
03/14/2007EP1761561A2 Antibody specificity transfer using minimal essential binding determinants
03/14/2007EP1761311A2 Antagonist anti-cd40 monoclonal antibodies and methods for their use
03/14/2007EP1761278A1 Adjuvant composition and methods for its use
03/14/2007EP1761277A1 West nile viruses with mutations in the 3' terminal stem and loop secondary structure for use as live virus vaccines
03/14/2007EP1761276A2 Compositions and methods for treating neurological disorders
03/14/2007EP1761275A2 Adjuvanted shiga toxin b-subunit based vaccines
03/14/2007EP1761264A1 Treatment with irinotecan (cpt-11) and an egfr-inhibitor
03/14/2007EP1497417B1 Epha2 antigen t epitopes
03/14/2007EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
03/14/2007EP1254180B1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody
03/14/2007EP1227838B1 Melanoma vaccine and methods of making and using same
03/14/2007EP1226169B1 Molecular structure of rhd negative locus
03/14/2007EP1196197B1 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
03/14/2007EP1098979B1 Antibody with improved producibility
03/14/2007EP1071411B1 Topical immunostimulation to induce langerhans cell migration
03/14/2007EP1067956B1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
03/14/2007EP0998941B9 Use of midkine or of anti-midkine antibodies
03/14/2007EP0966302B1 Methods of therapeutic administration of anti-cd40l compounds
03/14/2007CN1930288A Cells of which genome is modified
03/14/2007CN1930284A Infectious bursal disease virus antigenic isolates and vaccines
03/14/2007CN1930188A Estrogen receptors and methods of use
03/14/2007CN1930187A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
03/14/2007CN1930186A Media for clostridium bacterium and processes for obtaining a clostridial toxin
03/14/2007CN1930185A Canine vaccine for protection against ehrlichiosis
03/14/2007CN1930184A Novel TAT complexes, and vaccines comprising them
03/14/2007CN1929867A Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines
03/14/2007CN1929863A Antineoplastic combinations of CCI-779 and rituximab
03/14/2007CN1929862A Use of antagonist anti-CD40 antibodies for treatment of chronic lymphocytic leukemia
03/14/2007CN1929861A CTGF as target for the therapy of diabetic nephropathy
03/14/2007CN1929860A Site-specific chemical modification of HIV gp41-derived peptides
03/14/2007CN1929859A Method of vaccination against testicular BVDV infection
03/14/2007CN1929855A Method of inducing or modulating immune response
03/14/2007CN1929841A Pharmaceutical composition of (+)-erythro-mefloquine and its use
03/14/2007CN1928113A Function and application of RhoA/ROK alpha signal conduction path in blood vessel adventitia reconstruction
03/14/2007CN1928112A Expression of VEGF I type receptor on blood vessel adventitia fibroblast
03/14/2007CN1928095A Production method and product of escherichia coli ecesis factor antigen protein transgene plant
03/14/2007CN1928089A Total genome of HIV virus
03/14/2007CN1928076A Live vaccine for mycoplasma pneumonia of swine and production method thereof
03/14/2007CN1927887A Anti-rabies virus recombination immune toxin and preparation process
03/14/2007CN1927886A Preparation method and application of heterogenous resisting gosling blast yolk antibody for preventing and curing gosling blast
03/14/2007CN1927885A Preparation method of heterogenous yolk antibody for resisting gosling blast and viral hepatitis
03/14/2007CN1927881A Polypeptide, preparation method thereof, pharmaceutical composition and vaccine containing the same and application thereof
03/14/2007CN1927401A Self-assembly composite nano granule tumor vaccine and method for preparing same
03/14/2007CN1927397A Extraction method of animal blood plasma immunoglobulin oral administration preparation
03/14/2007CN1927396A Human avian influenza special target medicine and preparing method thereof
03/14/2007CN1927395A Method for preparation of freeze-dried chickenpox vaccine
03/14/2007CN1927394A Oral administration recombinant helicobacterpylori vaccine and preparing method thereof
03/14/2007CN1927137A Pre-transplant accommodated organs resistant to anti-donor immunity
03/14/2007CN1304427C Angiogenesis inhibiting fusion protein and its use
03/14/2007CN1304425C Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition
03/14/2007CN1304421C Peptides having affinity for the GP 120 viral protein and use thereof
03/14/2007CN1304420C Antigen simulating epipeptide of C type para chicken blood phili bacillus and its use
03/14/2007CN1304419C Antigen simulating epipeptide of A type parachicken blood phili bacillus and its use
03/14/2007CN1304410C Tumor necrosis factor-Gamma
03/14/2007CN1304056C Suspension-aid agent for vaccine of coccidiosis
03/14/2007CN1304051C PSGL-1 regulator
03/14/2007CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2
03/13/2007US7189837 Cell surface molecule-induced macrophage activation
03/13/2007US7189826 Hybridomas cell lines; viricides
03/13/2007US7189825 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy
03/13/2007US7189824 Monoclonal antibody which recognizes an antigen on the surface of tumor vessel endothelial cells; conjugates with diagnostic, chemotherapeutic agents for diagnosis or treatment of tumors
03/13/2007US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases
03/13/2007US7189819 Humanized antibodies that recognize beta amyloid peptide
03/13/2007US7189816 Antibody having a binding structure comprising specified complementarity determining region (CDR) sequences for a target tumor antigen on human gastrointestinal epithelial tumour cells; colon cancer diagnosis or immunotherapy
03/13/2007US7189815 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2007US7189809 Genetic engineered ioslated polynucleotide; anticholesterol agents, Alzheimer's disease, antilipemic agents
03/13/2007US7189805 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2007US7189800 Forming vaccines; analyzing hemagglutinin, calibration
03/13/2007US7189699 Polypeptide which interfers with amyloid formation
03/13/2007US7189698 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
03/13/2007US7189696 Peptide antagonists of zonulin and methods for use of the same
1 ... 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 ... 1823